B. Glaß

1.9k total citations
55 papers, 1.2k citations indexed

About

B. Glaß is a scholar working on Pathology and Forensic Medicine, Oncology and Hematology. According to data from OpenAlex, B. Glaß has authored 55 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pathology and Forensic Medicine, 18 papers in Oncology and 18 papers in Hematology. Recurrent topics in B. Glaß's work include Lymphoma Diagnosis and Treatment (25 papers), Immune Cell Function and Interaction (14 papers) and Hematopoietic Stem Cell Transplantation (14 papers). B. Glaß is often cited by papers focused on Lymphoma Diagnosis and Treatment (25 papers), Immune Cell Function and Interaction (14 papers) and Hematopoietic Stem Cell Transplantation (14 papers). B. Glaß collaborates with scholars based in Germany, United States and United Kingdom. B. Glaß's co-authors include Norbert Schmitz, L. Uharek, Peter Dreger, Jörg Steinmann, Matthias Zeis, Craig H. Moskowitz, Devinder Gill, Marek Trněný, Walter Gassmann and Nicolas Mounier and has published in prestigious journals such as Journal of Clinical Oncology, Blood and British Journal of Cancer.

In The Last Decade

B. Glaß

52 papers receiving 1.2k citations

Peers

Countries citing papers authored by B. Glaß

Since Specialization

Citations

This map shows the geographic impact of B. Glaß's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Glaß with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Glaß more than expected).

Fields of papers citing papers by B. Glaß

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Glaß. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Glaß. The network helps show where B. Glaß may publish in the future.

Co-authorship network of co-authors of B. Glaß

This figure shows the co-authorship network connecting the top 25 collaborators of B. Glaß. A scholar is included among the top collaborators of B. Glaß based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Glaß. B. Glaß is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Radiotherapy in Young, High-Risk Patients with Aggressive B-cell Lymphoma: Long-Term Results from the Open-Label, Randomized, Phase 3 R-MegaCHOEP Trial 2023 ·International Journal of Radiation OncologyBiologyPhysics ·Michael Oertel, Marita Ziepert, (unknown), (unknown), Maike Nickelsen, B. Glaß, Viola Poeschel, Christian Rübe, Georg Lenz, Norbert Schmitz, Hans Theodor Eich	1
2	Refractory or relapsed aggressive B-cell lymphoma failing (R)-CHOP: an analysis of patients treated on the RICOVER-60 trial 2017 ·Annals of Oncology ·B. Glaß, (unknown), Lorenz Truemper, Michael Pfreundschuh, Annalen Bleckmann, Gerald Wulf, Andreas Rosenwald, Marita Ziepert, Norbert Schmitz	5
3	Outcome of patients with relapsed diffuse large B-cell lymphoma who fail second-line salvage regimens in the International CORAL study 2015 ·Bone Marrow Transplantation ·Éric Van Den Neste, Norbert Schmitz, Nicolas Mounier, Devinder Gill, David C. Linch, Marek Trněný, Nöel Milpied, John Radford, Nicolas Ketterer, Ofer Shpilberg, Ulrich Dührsen, Dávid Ma, Josette Brière, Catherine Thiéblemont, Gilles Salles, Craig H. Moskowitz, B. Glaß, Christian Gisselbrecht	190
4	Maintenance with rituximab after autologous stem cell transplantation in relapsed patients with CD20 diffuse large B-cell lymphoma (DLBCL): CORAL final analysis. 2011 ·Journal of Clinical Oncology ·Christian Gisselbrecht, B. Glaß, G. Laurent, Devinder Gill, Mark Linch, Marek Trněný, Dominique Bron, Ofer Shpilberg, H Hagberg, Mario Bargetzi, (unknown), Josette Brière, Craig H. Moskowitz, (unknown)	18
5	High-dose therapy followed by autologous stem-cell transplantation with and without rituximab for primary treatment of high-risk diffuse large B-cell lymphoma 2010 ·Annals of Oncology ·B. Glaß, Marita Ziepert, Marcel Reiser, Mathias Freund, Lorenz Trümper, Bernd Metzner, Alfred C. Feller, Markus Loeffler, M. Pfreundschuh, Norbert Schmitz	24
6	Self‐tolerance of Human Natural Killer Cells Lacking Self‐HLA‐specific Inhibitory Receptors 2008 ·Scandinavian Journal of Immunology ·Justin Hasenkamp, (unknown), Markus Uhrberg, Christine S. Falk, Bjoern Chapuy, Gerald Wulf, Wolfram Jung, Lorenz Trümper, B. Glaß	8
7	Allogeneic transplantation in lymphoma: current status 2007 ·Haematologica ·Norbert Schmitz, Peter Dreger, B. Glaß, (unknown)	36
8	Current status and future perspectives for yttrium-90 (90Y)-ibritumomab tiuxetan in stem cell transplantation for non-Hodgkin's lymphoma 2007 ·Bone Marrow Transplantation ·C Gisselbrecht, Wolfgang Bethge, Rafael F. Duarte, A. M. Gianni, B. Glaß, Corinne Haïoun, Giovanni Martinelli, A Nagler, Ruth Pettengell, Anna Sureda, Hervé Tilly, Keith Wilson	14
9	A Prospective, Randomized Multicenter Trial of the Empirical Addition of Antifungal Therapy for Febrile Neutropenic Cancer Patients: Results of the Paul Ehrlich Society for Chemotherapy (PEG) Multicenter Trial II 2006 ·Infection ·Xaver Schiel, Hartmut Link, Georg Maschmeyer, B. Glaß, Oliver A. Cornely, Dieter Buchheidt, Martin Wilhelm, Gerda Silling, M. Helmerking, Wolfgang Hiddemann, Helmut Ostermann, Marcus Hentrich, (unknown)	26
10	Allogeneic hematopoietic cell transplantation following conditioning with⁹⁰Y-ibritumomab-tiuxetan 2005 ·Leukemia & lymphoma ·Thomas Fietz, L. Uharek, Chiara Gentilini, (unknown), Kathrin Rieger, (unknown), D. Sandrock, D. L. Munz, B. Glaß, E. Thiel, Igor Wolfgang Blau	23
11	Rhabdomyolysis in allogeneic peripheral blood stem cell donors 2004 ·Vox Sanguinis ·Julie Schanz, Claudia Wolf, María Koehler, J.H. Maas, Melissa A. Meyer, (unknown), (unknown), Gerald Wulf, B. Glaß, Lorenz Truemper, J. Riggert	4
12	Reduced-intensity conditioning prior to allogeneic transplantation of hematopoietic stem cells: the need for T cells early after transplantation to induce a graft-versus-lymphoma effect 2004 ·Bone Marrow Transplantation ·B. Glaß, Maike Nickelsen, Peter Dreger, Alexander Claviez, Justin Hasenkamp, Gerald Wulf, Lorenz Trümper, Norbert Schmitz	21
13	2-weekly vs 3-weekly CHOP with and without Etoposide in Young Patients with Low-Risk Aggressive Non-Hodgkins Lymphoma Results of the Completed NHL-B-1 Trial of the DSHNHL 2002 ·Blood ·Michael Pfreundschuh, Lorenz Truemper, Rudolf Schmits, Marita Kloess, (unknown), B. Glaß, Christian Rudolph, Andreas Engert, (unknown), D Hossfeld, Markus Loeffler, (unknown)	1
14	Elevated blood drug levels obtained from indwelling silicon catheters during oral cyclosporine A administration 2002 ·Bone Marrow Transplantation ·Alexander Claviez, B. Glaß, Peter Dreger, Maarten J. Suttorp	10
15	Autografting of highly purified peripheral blood progenitor cells following myeloablative therapy in patients with lymphoma: a prospective study of the long-term effects on tumor eradication, reconstitution of hematopoiesis and immune recovery 1999 ·Bone Marrow Transplantation ·Peter Dreger, (unknown), Nils von Neuhoff, (unknown), (unknown), B. Glaß, L. Uharek, Peter Rautenberg, Meinolf Suttorp, Bonnie Mills, (unknown), Norbert Schmitz	40
16	Investigating the lysis of small-cell lung cancer cell lines by activated natural killer (NK) cells with a fluorometric assay for NK-cell-mediated cytotoxicity 1999 ·Cancer Immunology Immunotherapy ·(unknown), B. Glaß, Matthias Zeis, Norbert Schmitz, L. Uharek	12
17	Early stem cell transplantation for chronic lymphocytic leukaemia: a chance for cure? 1998 ·British Journal of Cancer ·Peter Dreger, Nils von Neuhoff, R. Kuse, Ruth Sonnen, B. Glaß, L. Uharek, Robert Schoch, H. Löffler, Norbert Schmitz	43
18	Sequential high-dose therapy and autologous stem cell transplantation for treatment of mantle cell lymphoma 1997 ·Annals of Oncology ·Peter Dreger, Nils von Neuhoff, R. Kuse, Ruth Sonnen, B. Glaß, L. Uharek, H. Bartels, H. Löffler, Norbert Schmitz	19
19	Allogeneic MHC‐mismatched activated natural killer cells administered after bone marrow transplantation provide a strong graft‐versus‐leukaemia effect in mice 1997 ·British Journal of Haematology ·Matthias Zeis, L. Uharek, B. Glaß, Jörg Steinmann, Peter Dreger, W. Gaßmann, Norbert Schmitz	44
20	Induction of graft-versus-leukemia (GVL) activity in murine leukemia models after IL-2 pretreatment of syngeneic and allogeneic bone marrow grafts. 1994 ·PubMed ·Matthias Zeis, L. Uharek, B. Glaß, Tobias Gaska, W. Gaßmann, W Mueller-Ruchholtz	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact